Adrian Hargrave, CEO of SEEEN, explains how the new funds will accelerate customer growth Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCLIN.L Share News (CLIN)

  • There is currently no data for CLIN

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

AIM WINNERS & LOSERS: Rockhopper rises as Navitas enters project

Wed, 08th Dec 2021 11:45

(Alliance News) - The following stocks are the leading risers and fallers on AIM in London on Wednesday.

----------

AIM - WINNERS

----------

Rockhopper Exploration PLC, up 22% at 6.38 pence, 12-month range 4.50p-12.50p. The oil & gas exploration and production company says Navitas Petroleum LP is to enter its Sea Lion oil project in the Falkland Islands. Navitas replaces Harbour Energy PLC as Rockhopper's partner in the project.

----------

Equals Group PLC, up 12% at 70.40p, 12-month range 26.10p-73.00. The fintech payments firm says it has "significantly exceeded" its full-year expectations for both adjusted earnings and revenue. Group revenue for the year to date is GBP40.4 million, up 51% from GBP26.8 million for the same period in 2020. The strong revenue performance means increased gross profit and earnings, and Equals says it has exceeded its own full-year profitability forecasts, but does not provide a figure.

----------

Clinigen Group PLC, up 10% at 901.00p, 12-month range 541.50p-912.00p. Shares hit 12-month high after the pharmaceuticals and services provider agrees to be taken private by European investment firm Triton Funds in a GBP1.2 billion deal. Under the terms, Clinigen shareholders will receive 883p a share in cash. This is a 41% premium to the ex-dividend closing share price on December 1, which was the last business day before takeover talks were first announced. Clinigen shareholders will also be entitled to receive the previously declared final dividend of 5.46p a share.

----------

AIM - LOSERS

----------

Byotrol PLC, down 16% at 4.22p, 12-month range 4.00p-7.70p. Shares in the antimicrobial technologies company hit fresh 12-month low after profit warning and says its first half performance was below expectations. For six months to September 30, swings to pretax loss of GBP141,000 from GBP1.0 million profit year before. "Whilst we expect to be both profitable and cash generative in the second half of the year, with these uncertainties it is difficult to predict the quantum at this juncture. At present we are expecting IP sales to offset the majority of the anticipated shortfall in profit on product sale, but projecting the timing of IP sales is even more uncertain, so we feel it prudent to now reduce market guidance for the current financial year," it says.

----------

By Arvind Bhunjun; arvindbhunjun@alliancenews.com

Copyright 2021 Alliance News Limited. All Rights Reserved.

More News
30 Oct 2015 16:17

Dividends Calendar - Week Ahead

Read more
27 Oct 2015 07:54

Clinigen Says All Pharmaceutical Products Progressing As Expected

Read more
20 Oct 2015 15:29

AGM, EGM Calendar - Week Ahead

Read more
8 Oct 2015 15:05

Dividends Calendar - Week Ahead

Read more
7 Oct 2015 16:57

Clinigen directors cash in options

(ShareCast News) - Clinigen Group directors have taken home a nice mid-week bonus after three exercised their options and a fourth sold a large portion of his stake. Chief executive Peter George, deputy chief executive Shaun Chilton and chairman Peter Allen all exercised their options which were pro

Read more
22 Sep 2015 12:17

Clinigen to acquire Link and strengthen global footprint

(ShareCast News) - Clinigen Group has announced a proposed acquisition of Link Healthcare. The purchase, announced on Tuesday, would strengthen the pharmaceuticals company's global footprint in Asia, Africa and Australasia. Clinigen chief executive Peter George said Link had excellent local knowled

Read more
22 Sep 2015 07:04

REPEAT: Clinigen To Acquire Link Healthcare, Full Year Profit Hit By One-Offs (ALLISS)

Read more
22 Sep 2015 07:03

Clinigen To Acquire Link Healthcare, Full Year Profit Hit By One-Offs

Read more
21 Sep 2015 06:52

Clinigen Group To Launch Managed Access Programme With Neuraltus

Read more
17 Sep 2015 09:24

Clinigen Group strikes alliance to expand in US

(ShareCast News) - UK-based pharmaceuticals company Clinigen Group and US-based Cumberland Pharmaceuticals have struck a strategic alliance to expand each company's global reach. The deal will build on Clinigen's existing US relationships by providing support from Cumberland in the development, m

Read more
17 Sep 2015 08:13

Clinigen Group Signs Strategic Deal With Cumberland Pharmaceuticals

Read more
15 Sep 2015 15:20

Earnings, Trading Statements Calendar - Week Ahead

Read more
22 Jul 2015 07:16

Clinigen Says Gross Profit Up More Than 30% In Full Year

Read more
21 Jul 2015 07:56

Clinigen & Pharming Group RUCONEST Collaboration Now Live

Read more
5 Jun 2015 13:22

DIRECTOR DEALINGS SUMMARY: Rose Sells Booker As He Joins Quindell

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.